(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 9.27% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.93%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.26%.
Mckesson's revenue in 2025 is $359,051,000,000.On average, 7 Wall Street analysts forecast MCK's revenue for 2026 to be $50,784,730,218,781, with the lowest MCK revenue forecast at $50,392,118,388,571, and the highest MCK revenue forecast at $51,113,094,788,897. On average, 6 Wall Street analysts forecast MCK's revenue for 2027 to be $54,711,126,395,159, with the lowest MCK revenue forecast at $54,173,585,676,776, and the highest MCK revenue forecast at $55,391,440,693,224.
In 2028, MCK is forecast to generate $58,603,510,434,843 in revenue, with the lowest revenue forecast at $58,323,908,859,157 and the highest revenue forecast at $58,818,252,326,040.